FAKTOR OPTIONSSCHEIN - GENMAB Stock

Certificat

DE000PD4GEN1

Delayed Deutsche Boerse AG 10:21:01 2024-06-19 am EDT
0.055 EUR -8.33% Intraday chart for FAKTOR OPTIONSSCHEIN - GENMAB
Current month-27.71%
1 month-41.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-19 0.055 -8.33%
24-06-18 0.06 +1.69%
24-06-17 0.059 -9.23%
24-06-14 0.065 +1.56%
24-06-13 0.064 -5.88%

Delayed Quote Deutsche Boerse AG

Last update June 19, 2024 at 10:21 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying GENMAB A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD4GEN
ISINDE000PD4GEN1
Date issued 2020-09-14
Strike 1,810 kr
Maturity Unlimited
Parity 1 : 1
Emission price 2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.02
Lowest since issue 0.055
Spread 0.001
Spread %1.79%

Company Profile

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.2%); - income from research and development (12.4%); - other (4.4%): primarily income from partnership agreement. At the end of 2023, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase. Denmark accounts for all net sales.
Sector
-
More about the company

Ratings for Genmab A/S

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Genmab A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
1,810 DKK
Average target price
2,464 DKK
Spread / Average Target
+36.17%
Consensus